This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Implied Volatility Surging for Acadia Healthcare (ACHC) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Acadia Healthcare (ACHC) stock based on the movements in the options market lately.
Acadia Healthcare to Report Q4 Earnings: Can it Overcome Rising Costs?
by Zacks Equity Research
ACHC's fourth-quarter earnings are likely to have benefited from growing patient days and admissions.
Earnings Preview: Acadia Healthcare (ACHC) Q4 Earnings Expected to Decline
by Zacks Equity Research
Acadia Healthcare (ACHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks Industry Outlook Highlights HCA Healthcare, Tenet Healthcare, Universal Health, Acadia Healthcare and Community Health
by Zacks Equity Research
HCA Healthcare, Tenet Healthcare, Universal Health, Acadia Healthcare and Community Health have been highlighted in this Industry Outlook article.
Thriving in Healthcare: 5 Hospital Stocks to Keep on Your Radar
by Kaibalya Pravo Dey
The Zacks Medical-Hospital industry is likely to benefit from improving financial, operating and staffing stability. Companies like HCA, THC, UHS, ACHC and CYH are well-positioned to gain from these trends.
Will Acadia Healthcare (ACHC) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Acadia Healthcare (ACHC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
HCA Healthcare Pre-Q4 Earnings: Golden Opportunity or Fool's Gold?
by Zacks Equity Research
HCA's fourth-quarter results are expected to benefit from rising admissions and patient days. However, increasing expenses are a concern.
Community Health Drops 16.4% in 6 Months: Should You Hold or Fold?
by Zacks Equity Research
CYH's declining volumes and industry pressures raise concerns about its outlook despite efforts like strategic divestitures
Compelling Reasons to Retain Acadia Healthcare Stock Now
by Zacks Equity Research
ACHC remains well-poised for growth, attributable to sustained demand for behavioral healthcare services, as well as growth initiatives such as acquisitions, bed additions and joint ventures.
Should You Buy, Sell or Hold Pediatrix Medical Stock at a 9.28X P/E?
by Zacks Equity Research
Stable same-facility patient volume growth, inorganic initiatives and transition to an RCM structure should aid MD's future growth.
Is the Options Market Predicting a Spike in Acadia Healthcare (ACHC) Stock?
by Zacks Equity Research
Investors need to pay close attention to Acadia Healthcare (ACHC) stock based on the movements in the options market lately.
Acadia Healthcare (ACHC) Down 3.3% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Acadia Healthcare (ACHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Acadia Healthcare Stock Closer to 52-Week Low: A Buying Opportunity?
by Zacks Equity Research
ACHC is facing significant challenges, including lower returns, rising costs and declining free cash flow.
Brookdale Q3 Earnings Miss on Marketing Cost Hike, Shares Decline 18%
by Zacks Equity Research
BKD's Q3 results reflect higher marketing costs and lower interest income. Revenues and other operating income improve 3.5% year over year, driven by increased occupancy and RevPOR.
Zacks Industry Outlook HCA Healthcare, Tenet Healthcare, Universal Health, Acadia Healthcare and Community Health Systems
by Zacks Equity Research
HCA Healthcare, Tenet Healthcare, Universal Health, Acadia Healthcare and Community Health Systems have been highlighted in this Industry Outlook article.
5 Hospital Stocks Set to Thrive Amid Robust Industry Trends
by Zacks Equity Research
The Zacks Medical-Hospital industry is likely to gain from rising patient admissions and technological advancements. Companies like HCA, THC, UHS, ACHC and CYH are poised to gain from these trends.
Acadia Healthcare Shares Down 18.7% Despite Q3 Earnings Beat
by Zacks Equity Research
ACHC's better-than-expected third-quarter earnings benefit from higher patient days and improving volumes. Closing two facilities led the company to reduce its 2024 revenue guidance.
Acadia Healthcare (ACHC) Beats Q3 Earnings Estimates
by Zacks Equity Research
Acadia Healthcare (ACHC) delivered earnings and revenue surprises of 1.11% and 0.40%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Tenet Healthcare (THC) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Tenet (THC) delivered earnings and revenue surprises of 25.75% and 1.48%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Acadia Healthcare (ACHC) Q3 Earnings Expected to Decline
by Zacks Equity Research
Acadia Healthcare (ACHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
HCA Healthcare Pre-Q3 Earnings: Healthy Buy or a Diagnosis to Wait?
by Zubia Masood
HCA's third-quarter earnings are likely to benefit from improved admissions, capacity additions and payer mix, partially offset by rising operating expenses.
Analyzing Universal Health Pre-Q3 Earnings: Time to Buy the Stock?
by Debasmita Chatterjee
UHS' Q3 results are likely to be driven by rising admissions in acute care hospitals and higher revenue per adjusted patient day in behavioral health hospitals.
Acadia Healthcare Ventures in South Carolina With Three Buyouts
by Zacks Equity Research
ACHC expands its CTC network by acquiring three opioid treatment program clinics in South Carolina.
Will Acadia Healthcare (ACHC) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Acadia Healthcare (ACHC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.